📰 Arch News
Page 754 - Arch News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Arch. Real-time updates on events, politics, business and more.
March 31, 2023
PRESS RELEASE NOTICE OF DEPOSIT OF THE 2022 ANNUAL FINANCIAL REPORT 31 March 2023. Exprivia - a company listed on the... | March 31, 2023
March 31, 2023
PHOENIX, March 31, 2023 -- Global Water Resources, Inc. , a pure-play water resource management company, has declared, under its dividend policy, a monthly cash dividend in the amount of $0.02483... | March 31, 2023
March 31, 2023
TULIKIVI CORPORATION STOCK EXCHANGE RELEASE 31 MARCH 2023 AT 13:00 The Tulikivi Corporation annual report for 2022 includes the companys financial statements for 2022 and the auditors... | March 31, 2023
March 31, 2023
DAYTONA BEACH, Fla., March 31, 2023 -- Brown & Brown, Inc. announces it will release its 2023 first-quarter earnings on Monday, April 24, 2023, after the close of the market. On Tuesday, April... | March 31, 2023
March 31, 2023
ILKKA OYJ, STOCK EXCHANGE RELEASE, 31 March 2023 at 19:00 EET Ilkka Oyj – Acquisition of own shares on 31 March 2023 At Nasdaq Helsinki Ltd: Date31 March 2023Exchange transactionBuyShare... | March 31, 2023
March 31, 2023
Third Point Investors Ltd - Weekly Estimate Net Asset Value - March 2023 PR Newswire London, March 31 Third Point Investors Limited (the "Company") (a closed-ended investment
March 31, 2023
BURLINGTON, N.C., March 31, 2023 /PRNewswire/ -- Labcorp , a leading global life sciences company, will release its financial results for the first quarter of 2023 before the market opens on... | March 31, 2023
March 31, 2023
Item 7.01 Regulation FD Disclosure. On March 31, 2023, Distribution Solutions Group, Inc., a Delaware corporation , issued a press release announcing that it has entered into a Stock Purchase... | March 31, 2023
March 31, 2023
The Senate passed a resolution March 29 that would expedite the end of the COVID-19 national emergency from its planned May 11 deadline to immediately upon the signature of the president, and President Joe Biden has reportedly indicated he will sign it.
March 31, 2023
BOSTON and ATLANTA, March 31, 2023 /PRNewswire/ -- Inhibikase Therapeutics, Inc. , a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of... | March 31, 2023